Processa Pharmaceuticals names Gregory J. Flesher chief operating officer
PCSA•Processa Pharmaceuticals appointed Gregory J. Flesher chief operating officer and named Craig Coburn, Ashley Hall and Michael P. Cruse to executive vice president roles.
1. Executive appointments
Processa Pharmaceuticals appointed biotechnology executive Gregory J. Flesher as chief operating officer. Craig Coburn was named executive vice president and head of research, Ashley Hall was appointed executive vice president of development, and Michael P. Cruse was named executive vice president of business operations.
